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Abstract
Regulatory T cells (Tregs) were identified several years ago and are key in controlling autoimmune diseases and limiting
immune responses to foreign antigens, including alloantigens. In vivo imaging techniques including intravital microscopy as
well as whole body imaging using bioluminescence probes have contributed to the understanding of in vivo Treg function,
their mechanisms of action and target cells. Imaging of the human sodium/iodide symporter via Single Photon Emission
Computed Tomography (SPECT) has been used to image various cell types in vivo. It has several advantages over the
aforementioned imaging techniques including high sensitivity, it allows non-invasive whole body studies of viable cell
migration and localisation of cells over time and lastly it may offer the possibility to be translated to the clinic. This study
addresses whether SPECT/CT imaging can be used to visualise the migratory pattern of Tregs in vivo. Treg lines derived from
CD4
+CD25
+FoxP3
+ cells were retrovirally transduced with a construct encoding for the human Sodium Iodide Symporter
(NIS) and the fluorescent protein mCherry and stimulated with autologous DCs. NIS expressing self-specific Tregs were
specifically radiolabelled in vitro with Technetium-99m pertechnetate (
99mTcO4
2) and exposure of these cells to radioactivity
did not affect cell viability, phenotype or function. In addition adoptively transferred Treg-NIS cells were imaged in vivo in
C57BL/6 (BL/6) mice by SPECT/CT using
99mTcO4
2. After 24 hours NIS expressing Tregs were observed in the spleen and
their localisation was further confirmed by organ biodistribution studies and flow cytometry analysis. The data presented
here suggests that SPECT/CT imaging can be utilised in preclinical imaging studies of adoptively transferred Tregs without
affecting Treg function and viability thereby allowing longitudinal studies within disease models.
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Introduction
Regulatory T cells (Tregs) are key players in the adaptive
immune system. Tregs are responsible for maintaining immune
homeostasis and self-tolerance by preventing autoimmunity and
limiting immune responses to foreign antigens such as alloantigens
[1]. The regulatory function of Tregs on CD4
+ or CD8
+ effector T
cells (Teff) has made them a potential immunotherapy agent for
clinical treatments of various diseases [2]. Applications of Tregs in
the field of transplantation has been recognised as adjunct therapy
to immunosuppressive drugs to induce transplantation tolerance
[3]. Adoptive transfer of murine derived Tregs has been a
successful strategy in the prevention of graft rejection and in the
cure of autoimmune diseases such as diabetes. More recently
injection of human Tregs into humanised mouse models lead to
the protection from vessel and skin transplant pathology [4,5].
Furthermore, injection of ex-vivo expanded Tregs has been used in
clinical trials to prevent Graft versus Host Disease (GvHD) in bone
marrow transplant patients [6].
However, to date the mechanisms by which adoptively
transferred Treg function in vivo and where they exert their
suppressive function remains unclear. Imaging techniques have
been utilised to gain some understanding of their mechanisms of
action and location. Intravital two-photon laser scanning micros-
copy was utilised by Tang et al (2006) to demonstrate that
suppression of T cells was a consequence of the interaction between
Tregs and DCs [7]. In another study, Zhang et al (2009) utilised
immunofluorescent imaging of adoptively transferred Tregs in an
islet transplant model and observed that Treg sequential migration
from blood to tissue and then to the draining lymph nodes was
required for their optimal suppressive capacity in vivo [8]. In another
study, fluorescent imaging was utilised to demonstrate that the
aforementioned sequential migration of Tregs was necessary for
optimal suppression during a skin immune response in the form of
contact hypersensitivity [9]. Although these studies have helped in
understanding Treg function in vivo there are some limitations
associated with the imaging techniques utilised. The major
drawback in using intravital microscopy as an initial imaging
PLoS ONE | www.plosone.org 1 October 2011 | Volume 6 | Issue 10 | e25857technique is that the location of the cells of interest needs to be
known (which is predominately limited by the technique to the skin
or lymph nodes) and the optimal time to image. The major
advantage of whole body imaging using radioisotopes is that it is a
fully quantitative technique and one is not biased or limited by the
‘‘expected’’ biodistribution of the cells of interest.
Imaging modalities such as Positron Emission Tomography
(PET) and Single Photon Emission Computed Tomography
(SPECT) are routine clinical imaging techniques used within
Nuclear Medicine and have been utilised to image various cells
including T cells [10,11,12,13]. Cells visualised with these
techniques can be labelled directly or via reporter gene mediated
uptake of radioisotopes [13]. Although direct radiolabelling of cells
can be a rapid procedure, it has the disadvantage of being short
lived, not linked to cell viability and not necessarily imaging of the
labelled cells of interest (i.e. labelled cells undergo cell death and
the radiolabel passes to phagocytic cells) [13]. In contrast, receptor
mediated radiolabelling does not have these limitations and has
the potential to image viable cells longitudinally. The expression of
the reporter gene human Sodium Iodide Symporter (NIS) and the
incorporation of isotopes such as Technetium-99m pertechnetate
(
99mTcO4
2), Rhenium-188 perrhenate and Iodine through NIS
has been utilised to label and image various cells such as
hepatocarcinoma cells, cervix tumour cells, glioma cells and
mammary gland cells [14,15,16,17,18].
In this study, we investigated whether Tregs can be transduced
to express NIS and whether NIS expressing Tregs maintained
their phenotype and functions when radiolabelled in vitro and
finally whether they could be imaged in vivo using NanoSPECT/
CT. The results from this study suggest that SPECT technology is
a useful tool for tracking Tregs in vivo longitudinally and to help in
understanding Treg migration, distribution, mechanism of action
and life span in various disease models.
Materials and Methods
Ethics statement
Animalstudieswerecarriedoutinaccordancewith UKResearch
Councils’ and Medical Research Charities’ guidelines on Respon-
sibility in the Use of Animals in Bioscience Research, under a UK
Home Office license (PPL 70/6473; Title: Mechanisms of immu-
nological response to foreign antigens).
Mice, culture media, reagents, antibodies and Flow
cytometric analysis
C57BL/6(BL/6)(H-2
b)miceaged6–8weeksoldwerepurchased
from Harlan. RPMI 1640 medium supplemented with L-glutamine
(Gibco, Invitrogen), penicillin/streptomycin (Gibco, Invitrogen),
and 10% (v/v) FCS (PAA Laboratories) was used for all in vitro
assays. Anti-CD4–FITC (clone GK1.4), anti-FoxP3–APC (clone
FJK-16s) and anti-CD25–PE (clone PC61) were purchased from
eBioscience. All flow cytometry analysis was conducted on a BD
FACS LSR II using FACs DIVA software (BD Biosciences). For
surface staining, 5610
5 cells were incubated with saturating
concentrations of appropriate antibodies for 30 minutes at 4uC,
then washed twice in cold FACS buffer (PBS with 1% [v/v] FCS)
before analysis. For intracellular staining of FoxP3, a mouse FoxP3
staining kit was used (eBioscience) according to manufacturer’s
protocol.
Cell preparation
Tregs: Treg lines were generated as described earlier [19].
Briefly, CD4
+CD25
+ Tregs were isolated from the lymph nodes
and spleen of BL/6 mice using a CD4
+CD25
+ selection kit
(Miltenyi Biotec). For generation of Treg lines, self-specific
CD4
+CD25
+ Tregs (2610
6 cells/mL) were stimulated once per
week with immature BL/6 DCs (0.5610
6/mL) in the presence of
10 U/mL of IL-2 in a 24-well plate.
DC: Bone marrow derived DCs (BM-DCs) were generated as
described earlier [20] according to the protocol described by Inaba
and colleagues [21]. Briefly, the bone marrow was treated with
ACK lysing buffer and incubated for 30 minutes at 4uC with anti-
CD4, -CD8, -B220 and anti-MHC Class II supernatants
(YTS169, YTS191, RA34.5, M5/114 respectively). Cells were
washed with RPMI and Dynal beads (Gibco, Invitrogen) coated
with goat anti-rat IgG were then added. Beads and cells were
incubated for 30 minutes at 4uC before being placed on a magnet.
DCs were then cultured at 37uC/5% CO2 using FCS media
supplemented with mouse GM-CSF. Media was changed on days
2 and 4 to remove non-adherent cells. DCs were used on day 6 of
culture.
Production of NIS vector, retroviral supernatant and
retroviral transduction
Retroviral supernatant was produced as previously described
[19] with the following modification. The MSCV (Murine Stem
Cell Virus) MIGR1 vector [22] was modified to contain human
NIS followed by the IRES element and mCherry. NIS in the
pcDNA3 vector [23] was amplified by PCR using the forward
primer 59-CAC CAC CTC GAG GCT GTC AGC GCT GAG
CAC AGC and reverse primer 59-CAC CAC GAA TTC TTT
GGC CCA TCC TGA GGA ACC. The resulting PCR product
was digested with the restriction enzymes XhoI and EcoRI (NEB)
and ligated into the XhoI and EcoRI digested MIGR1 vector.
Next, mCherry obtained from the lab of Professor R.Y. Tsien [24]
was amplified by PCR using the forward primer 59-CAC CAC
GGT CTC CCA TGC GCC ACC ATG GTG AGC AAG G and
reverse primer 59- CAC CAC GTC GAC CTT GTA CAG CTC
GTC CAT GCC. This PCR product was digested with Esp3I,
leaving an NcoI-compatible overhang, and SalI, and subsequently
ligated into the NIS containing MIGR1 vector that had been
digested with NcoI and SalI, which had removed the GFP. The
resulting pNImC vector was analyzed for the correct sequence and
then transfected into Phoenix-Eco packaging cells using CaPO4.
Supernatant was collected on day 2. For retroviral transduction,
Tregs were first activated with autologous DCs and anti-CD3e
(1 mg/mL) for 48 hours. The activated cells were then transferred
to a RetroNectin-coated (Takara) 24-well plate (2–3610
6/mL in
single well of 24-well plate) with 50% (v/v) retroviral supernatant
supplemented with 10 U/mL of IL-2 and cultured at 37uC for
24 hours. Supernatants were removed, and the cells cultured in
fresh medium supplemented with 10 U/mL of IL-2. The NIS
transduced self-specific Tregs (B6s-NIS) were enriched by flow
cytometry cell sorting (BD FACS Aria II cell sorter) by gating on
the mCherry positive cells.
Treg Suppression Assay. Tregs (50 mlo f1 610
6 cells/mL)
were co-cultured with CD4
+ T cells (50 mlo f1 610
6 cells/mL)
isolated from BL/6 mice in the presence of T cell–depleted
splenocytes generated from BL/6 mice (5o mlo f2 610
6 cells/mL)
and anti-CD3e (1 mg/mL) in a 96-well plate. Proliferation was
assessed by measuring [
3H] thymidine incorporation during the
last 18 hours of a 3-day culture.
In vitro radiolabelling and cell viability assays
For assessing receptor mediated
99mTcO4
2 uptake in vitro,
transduced (B6s-NIS) and non-transduced (B6s) Tregs were washed
in Hank’s Balanced Salt solution (Gibco, Invitrogen) before 1610
6
Tregs were incubated with 1 MBq of
99mTcO4
2 (kindly provided
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15 minutes at 37uC. Cells were then pelleted and the supernatant
carefully removed. The amount of
99mTcO4
2 uptake was assessed
using a Compugamma 1281 gamma counter (LKB Wallac).
Included in same experiment was the NIS inhibitor, Sodium
Perchlorate (100 mMp e r1 610
6 cells). The toxicity effect of
radioactivity on B6s-NIS Tregs was measured using a standard
MTT assay (Molecular Probes, Invitrogen). B6s-NIS Tregs (1610
6)
were incubated with 0–100 MBq of
99mTcO4
2 for 15 minutes at
37uC. Cells were suspended in FCS containing media without
Phenol red and 1610
5 B6s-NIS Tregs were then plated into a 96-
well plate in triplicates and a MTT assay was carried out according
to manufacturer’s protocol. Plates were read at a wavelength of
570 nm using a Bio-Tek EL800 automatic plate reader (Wolf
laboratories).
Also 1610
6 B6s-NIS Tregs cells were radiolabelled with 30 MBq
of
99mTcO4
2 and suppression assay performed as described above.
Adoptive transfer and NanoSPECT/CT imaging of Tregs in
vivo
BL/6 mice were injected intravenously (i.v) with 1610
6
Carboxyfluorescein succinimidyl ester (CFSE) labelled (1 mM,
Molecular Probes, Invitrogen) B6s-NIS Tregs 24 hours before
imaging. On the day of scanning, 20 MBq of
99mTcO4
2 was
administered i.v and the mouse was imaged, under inhaled
isofluorane anaesthetics for 1 hour using a NanoSPECT/CT
preclinical imager (Bioscan) equipped with a multipinhole (nine
pinholes, aperture 1.0 mm) collimator. Images were then recon-
structed using the Invivoscope software (Bioscan). Mice were then
culled and
99mTcO4
2 biodistribution studies and FACS analysis
Figure 1. Tregs transduced with NIS maintained their phenotype and suppressive function in vitro.A ) NIS transduced B6s Tregs were
sorted by flow cytometry based on mCherry expression to 96.14%. NIS expressing Tregs co-express mCherry as shown using fluorescence
microscopy. B)5 610
5 Tregs were stained for CD4-FITC, CD25-PE and FoxP3-APC. The result shown here are representative of 3 different experiments
based on live cells using the forward and side scatter plots. C) Suppressive function of Treg. 5610
4 freshly isolated CD4
+ T cells were cultured alone,
or with transduced or non-transduced 5610
4 Tregs, in the presence of 1 mg/mL soluble purified anti- CD3e and 1610
5 APC. T cell proliferation was
measured by [
3H]-thymidine incorporation (cpm) at 72 h of culture. Results are presented as mean cpm values of triplicate wells with standard error
of the mean (SEM). **, P,0.003.
doi:10.1371/journal.pone.0025857.g001
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of
99mTcO4
2 were calculated by the formula: [CPM (organ)/
weight (organ)]/[CPM (whole mouse)/weight (whole mouse)].
Statistics
Data are expressed as mean of triplicates 6 SEM. Significance
between 2 groups (B6s and B6s-NIS Tregs) was calculated using
unpaired 2-tailed t test using GraphPad Prism 5 software. P values
less than 0.05 were considered statistically significant.
Results
Tregs transduced with NIS maintain their phenotypic and
suppressive function
Previously we have demonstrated that self-specific Tregs
generated from BL/6 mice stimulated with autologous DCs and
IL-2 were suppressive in vitro and in vivo [19]. We have also shown
that Tregs can be retrovirally transduced with myeloproliferative
sarcoma virus to express an antigen-specific T cell receptor (TCR)
whilst retaining their phenotypic and suppressive function [19]. In
order to track adoptively transferred Tregs in vivo we employed a
strategy by which we generated Tregs with defined antigen
specificity and expressing the reporter gene NIS. Treg lines
specific for self-MHC, generated from CD4
+CD25
+FoxpP3
+ T
cells, were retrovirally transduced with a DNA construct
containing NIS and mCherry separated by a bicistronic IRES
element. Although initially the transduction efficiency was low,
with only 0.05% of Tregs expressing mCherry (data not shown),
these cells (B6s-NIS Tregs) were expanded with autologous DCs
and IL-2 and subsequently enriched for mCherry expression by
flow cytometry cell sorting to achieve a population of cells that was
96% positive for mCherry expression (Fig. 1A). These B6s-NIS
Tregs expressed similar levels of CD4, CD25 and FoxP3
compared to their non-transduced (B6s Tregs) counterparts
(Fig. 1B) as well as maintaining their suppressive capacity
(Fig. 1C). These observations suggested that retroviral adminis-
tration of NIS and mCherry genes to CD4
+CD25
+FoxP3
+ T cells
and subsequent expansion did not alter their phenotype and
suppressive function.
NIS expressing Tregs can be radiolabelled with
99mTcO4
2
in vitro
Previous studies have shown that cells such as rat glioma cells
expressing NIS can be radiolabelled in vitro and in vivo with
99mTcO4
2 [25]. As we plan to image NIS expressing Tregs in vivo
using this radiolabel it was important to show that these cells
express NIS and that the levels of NIS expressed was sufficient for
mediated radiolabelling. NIS mediated uptake of
99mTcO4
2 was
assessed by incubating both the NIS expressing Tregs and the
parental line with 1 MBq of
99mTcO4
2 per 1610
6 cells.
Incubation of NIS expressing Tregs with
99mTcO4
2 resulted in
accumulation of significant levels of this radiolabel into the cells
(p=0.0012) (Fig. 2). Moreover, further confirmation of the
specificity of this receptor-mediated uptake was shown by addition
of sodium perchlorate prior to radiolabelling. This chemical has
previously been shown to inhibit the NIS receptor [18]. As
expected, radiolabelling of
99mTcO4
2 in the transduced cells was
inhibited in the presence of sodium perchlorate (Fig. 2).
Tregs radiolabelled with
99mTcO4
2 maintained their
viability, phenotype and suppressive function
As we wish to follow our Tregs longitudinally and throughout the
lifespan of an immune response it was important to ensure that
exposure to
99mTcO4
2 did not affect the viability, phenotype or the
function of NIS expressing Tregs. The NIS Tregs were exposed to
increasing amounts of
99mTcO4
2, ranging from 0–100 MBq per
1610
6 cells in vitro. Up to 25 MBq of
99mTcO4
2 did not affect the
viability of cells as measured by an MTT assay (Fig. 3A). As shown
in Figure 3A cell death was seen only after incubation with 50 or
100 MBq (p=0.0154 and p=0.0006 respectively) of
99mTcO4
2 as
compared to unlabelled Tregs.
The effect of NIS mediated radiolabelling on the phenotype and
suppressive function of Tregs was also analysed. In order to do so,
NIS expressing Tregs were exposed to 30 MBq of
99mTcO4
2 per
Figure 2. B6s-NIS Tregs uptake
99mTcO4
2 in vitro. 1610
6 B6s or B6s-NIS Tregs were incubated in Hank’s Balanced Salt solution supplemented
with 1 MBq of
99mTcO4
2. Sodium Perchlorate (100 mM) was used to block the
99mTcO4
2 uptake by B6s-NIS Treg line. **, P,0.0082.
doi:10.1371/journal.pone.0025857.g002
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as well as the suppressive function were studied 7 days later.
99mTcO4
2 exposed B6s-NIS Tregs had similar surface levels of
CD4, CD25 molecules and intracellular expression of FoxP3 as
B6s-NIS Tregs not exposed to this radiolabel (Fig. 3B). In addition,
no significant effect (p=0.9296) on the suppressive capability of
Tregs was observed following exposure to this radioisotope
(Fig. 3C). From these observations we conclude that radiolabelling
of B6s-NIS Tregs with
99mTcO4
2 did not alter their viability,
phenotype and suppressive capacity.
NIS expressing Tregs can be imaged in vivo using
NanoSPECT/CT
Next the in vitro observations with NIS expressing Tregs were
extended in vivo. CFSE labelled NIS expressing Tregs were
adoptively transferred into recipient BL/6 mice. One day later,
mice were injected intravenously with
99mTcO4
2 and imaged using
NanoSPECT/CT. As expected, endogenously NIS expressing
organs such as thyroid, stomach and salivary glands accumulated
high levels of
99mTcO4
2 (Fig. S1). Removal of these endogenously
NISsignalsusing imaging softwareallowed thevisualisationofother
organs in which accumulated
99mTcO4
2 was present. The
NanoSPECT/CT image of B6s-NIS Tregs and
99mTcO4
2 injected
mice showed an accumulation of signal within the spleen (Fig. 4A).
This was not observed in mice injected with non-transduced Tregs
and
99mTcO4
2 (Fig. S2). To further confirm these observations,
mice were culled and
99mTcO4
2 levels was measured in the vital
organs (Fig. 4B). The results from the biodistribution analysis
confirmed that the NIS expressing Tregs migrated to the spleen
following adoptive transfer and they were radiolabelled in vivo with
99mTcO4
2. When the levels of
99mTcO4
2 in the spleens of animals
receiving either B6s-NIS or B6s Tregs were compared a significant
increase (p,0.0082) in radiolabel uptake was seen in the spleens of
mice receiving NIS expressing Tregs (Fig. 4C). Lastly, we confirmed
that the radioactive signals seen in the spleens, both in the scan and
in the organ biodistribution, were due to the presence of NIS Tregs
Figure 3. Effect of
99mTcO4
2 uptake on the viability, phenotype and suppressive function of Tregs. A) Standard MTT assay was
performed using 1610
6 B6s-NIS Tregs incubated in the presence of Hank’s buffer supplemented with increasing
99mTcO4
2 (ranging from 0–100 MBq
of
99mTcO4
2) in triplicates in a 96 well plate. B) B6s-NIS Tregs were incubated with or without
99mTcO4
2 (30 MBq per million cells) and cultured in
vitro for 7 days. These Tregs were then harvested for phenotypic and suppressive function. 5610
5 Tregs were stained with anti-CD4-FITC, anti-CD25-
PE and anti-FoxP3-APC. Plots shown here are gated on live cells using the forward and side scatter plots. C)
99mTcO4
2 labelling had no effect on
suppressive function of B6s-NIS Tregs. 5610
4 freshly isolated CD4
+ T cells were cultured alone, or with 5610
4 transduced Tregs, in the presence of
1 mg/mL soluble purified anti-CD3e and 1610
5 APC. T cell proliferation was measured by [
3H]-thymidine incorporation (cpm) at 72 h of culture.
*, P,0.01; **, P,0.002; ***, P,0.0007.
doi:10.1371/journal.pone.0025857.g003
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this organ via flow cytometry. Indeed, CFSE positive Tregs were
present in the spleens of mice receiving NIS or untransduced Tregs
(Fig. 4D) confirming that the differences in
99mTcO4
2 levels noticed
was due to NIS expressing cells residing in the spleen rather than
passive uptake of this radioisotope.
We concluded that Tregs expressing NIS can be radiolabelled
with
99mTcO4
2 in vitro and more importantly in vivo as shown by
NanoSPECT/CT. Furthermore, we observed that adoptively
transferred Tregs were located predominantly within the spleen of
recipient mice 24 hours after administration.
Discussion
It is well established that Tregs have an important role in down-
regulating the immune response. It is this suppressive function of
Figure 4. B6s-NIS Tregs can be imaged in vivo by NanoSPECT/CT through in vivo uptake of
99mTcO4
2.A ) BL/6 mice were adoptively
transferred with 1610
6 CFSE labelled B6s-NIS Tregs 24 hours later mice received 20 MBq of
99mTcO4
2 before being imaged using NanoSPECT/CT
under general anaesthesia for 1 hour. The white arrow indicates the spleen in different views of scan. B) After scanning, mice were culled and vital
organs were analysed for levels of
99mTcO4
2. The graph illustrates the mean of Standard Uptake Value (SUV) of the organs (n=3 mice). C) The SUV of
spleens from mice adoptively transferred with B6s or B6s-NIS Tregs. Spleens containing B6s-NIS had significantly more
99mTcO4
2 uptake (n=6 per
group). D) Flow Cytometry data showing the SSC and CFSE demonstrates the presence of CFSE labelled B6s-NIS Tregs in the spleen of injected mice.
**, P,0.0082.
doi:10.1371/journal.pone.0025857.g004
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and therapy for immune related diseases such as autoimmune
diseases and transplantation. Various imaging based studies have
helped in dissecting some of the mechanisms of action of Tregs
[26] these include: 1) the importance of Treg-DC interaction for
Treg function [27], 2) the relevance of sequential migration of
Tregs from blood to graft and then to the draining lymph node for
graft survival [8] and 3) during a skin immune response in the
form of contact hypersensitivity [9]. However, there are some
limitations associated with the imaging techniques used in the
reported studies including the difficulty of their translation to the
clinical studies [28]. PET and SPECT are examples of imaging
techniques that are used in the nuclear medicine and allows
tracking and monitoring of cells in the whole body for long periods
of time [13]. Immune cells have been so far directly radiolabelled
for imaging using PET and SPECT, and the major disadvantage
of this approach is that they can be visualised for very short period
depending upon the half-life of the radioisotope used [13].
Radiolabelling cells through NIS, used in our study, allows
receptor mediated uptake of specific radioisotopes such as
99mTcO4
2 for as long as the cells are alive. Tumour cell lines
expressing NIS have been generated and adoptively transferred
into animals to study in vivo cancer development and tumour
therapy [18]. These studies suggest that receptor mediated
radiolabelling can be utilised to image adoptively transferred cells.
However we are the first group to utilise NIS mediated labelling to
track immune cells and in particular Tregs. We have demonstrat-
ed that Tregs can be retrovirally transduced to express NIS
without any alteration to their phenotype and function in vitro. B6s-
NIS Tregs were enriched by cell sorting based on the expression of
mCherry, as previously reported [29]. We then demonstrated that
NIS expressing Tregs can be radiolabelled in vitro and more
importantly in vivo with
99mTcO4
2 and that this radiolabelling is
NIS dependent. In addition, exposure to less than 30 MBq of
99mTcO4
2 per 1610
6 of cells did not alter the phenotype or the
suppressive function of B6s-NIS Tregs. Therefore, for in vivo
uptake and imaging studies, 30 or less MBq of
99mTcO4
2 was
utilised. Finally we observed that NIS expressing Tregs are located
within the spleen of recipient mice 24 hours following adoptive
transfer and injection of
99mTcO4
2 in mice using NanoSPECT/
CT as previously demonstrated with adoptively transferred T cells
using SPECT [30] Bioluminescence and PET Imaging [31].
Adoptivetransfer of NIS transduced Tregs willallow the expansion
of our knowledge regarding the life span, localization, distribution
and migration patterns of these cells in various models. Furthermore,
the influence of antigen-specificity for Treg localisation and function
can be investigated, having demonstrated that murine and human
antigen-specific Tregs are superior comparing to polyclonal Tregs in
protecting from heart andskin transplant rejections [5,19].Moreover,
Tregs have been shown to be heterogeneous in phenotype and
function [32]. The PET and SPECT imaging technology could help
in clarifying the mechanism of action and migration patterns of Treg
subsets in vivo. Finally this technology is a pre-clinical imaging
technique making it applicable for clinical studies of adoptive Treg
therapy to further refine future strategies to induce tolerance in the
context of transplantation and autoimmune diseases.
Supporting Information
Figure S1 B6s-NIS Tregs can be imaged in vivo using
NanoSPECT/CT. BL/6 mice were adoptively transferred with
1610
6 CFSE labelled B6s-NIS Tregs 24 hours later mice received
20 MBq of
99mTcO4
2 before being imaged using NanoSPECT/
CT under general anaesthesia for 1 hour. A) SPECT/CT Image
acquired showing Stomach, Salivary glands and Thyroid. B) Using
the InvivoScope software, the signals from Stomach was removed
allowing the visualisation of the spleen.
(AVI)
Figure S2 B6s Tregs cannot be imaged in vivo using
NanoSPECT/CT. BL/6 mice were adoptively transferred with
1610
6 CFSE labelled B6s Tregs 24 hours later mice received
20 MBq of
99mTcO4
2 before being imaged using NanoSPECT/
CT under general anaesthesia for 1 hour. A) SPECT/CT Image
acquired showing Stomach, Salivary glands and Thyroid. B) Using
the InvivoScope software, the signals from Stomach was removed.
C) After scanning, mice were culled and vital organs were analysed
for levels of
99mTcO4
2. The graph illustrates the mean of
Standard Uptake Value (SUV) of the organs (n=3 mice).
(AVI)
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